GSK logo

GSK (GSK) Short Term Debt

Annual Short Term Debt

$3.58 B
-$1.20 B-25.07%

31 December 2023

GSK Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Short Term Debt

$3.77 B
-$490.26 M-11.52%

30 September 2024

GSK Quarterly Short Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

GSK Short Term Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-25.1%-36.3%
3 y3 years-29.4%-42.4%
5 y5 years-51.3%-62.7%

GSK Short Term Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-29.4%at low-49.6%+20.8%
5 y5 years-60.5%at low-62.7%+20.8%
alltimeall time-60.5%+2108.8%-70.7%+2222.0%

GSK Short Term Debt History

DateAnnualQuarterly
Sept 2024
-
$3.77 B(-11.5%)
June 2024
-
$4.26 B(+28.9%)
Mar 2024
-
$3.30 B(-7.8%)
Dec 2023
$3.58 B(-25.1%)
$3.58 B(-39.4%)
Sept 2023
-
$5.91 B(-20.9%)
June 2023
-
$7.47 B(+41.5%)
Mar 2023
-
$5.28 B(+10.3%)
Dec 2022
$4.78 B(-1.6%)
$4.78 B(+53.3%)
Sept 2022
-
$3.12 B(-22.7%)
June 2022
-
$4.04 B(-25.1%)
Mar 2022
-
$5.39 B(+10.9%)
Dec 2021
$4.86 B(-4.3%)
$4.86 B(-25.7%)
Sept 2021
-
$6.54 B(-6.3%)
June 2021
-
$6.98 B(+60.0%)
Mar 2021
-
$4.36 B(-14.1%)
Dec 2020
$5.08 B(-44.0%)
$5.08 B(-19.7%)
Sept 2020
-
$6.32 B(-13.9%)
June 2020
-
$7.34 B(-18.3%)
Mar 2020
-
$8.99 B(-0.9%)
Dec 2019
$9.07 B(+23.4%)
$9.07 B(-10.2%)
Sept 2019
-
$10.10 B(-21.5%)
June 2019
-
$12.86 B(+17.2%)
Mar 2019
-
$10.97 B(+49.3%)
Dec 2018
$7.35 B(+92.5%)
$7.35 B(+94.4%)
Sept 2018
-
$3.78 B(-16.7%)
June 2018
-
$4.54 B(-6.0%)
Mar 2018
-
$4.82 B(+26.4%)
Dec 2017
$3.82 B(-24.7%)
$3.82 B(-40.0%)
Sept 2017
-
$6.37 B(-26.0%)
June 2017
-
$8.60 B(+84.3%)
Mar 2017
-
$4.67 B(-8.0%)
Dec 2016
$5.07 B(+161.8%)
$5.07 B(-1.2%)
Sept 2016
-
$5.13 B(-15.0%)
June 2016
-
$6.04 B(+240.7%)
Mar 2016
-
$1.77 B(-8.6%)
Dec 2015
$1.94 B(-57.7%)
$1.94 B(-10.1%)
Sept 2015
-
$2.15 B(-44.6%)
June 2015
-
$3.89 B(-19.0%)
Mar 2015
-
$4.80 B(+4.7%)
Dec 2014
$4.58 B(-0.4%)
$4.58 B(-47.2%)
Sept 2014
-
$8.67 B(+62.0%)
June 2014
-
$5.35 B(+73.2%)
Mar 2014
-
$3.09 B(-32.8%)
Dec 2013
$4.60 B(-21.6%)
$4.60 B(+3.4%)
Sept 2013
-
$4.45 B(+25.0%)
June 2013
-
$3.56 B(+15.8%)
Mar 2013
-
$3.07 B(-47.6%)
Dec 2012
$5.87 B(+41.1%)
$5.87 B(-13.0%)
Sept 2012
-
$6.74 B(+18.8%)
June 2012
-
$5.67 B(+30.6%)
Mar 2012
-
$4.34 B(+4.5%)
Dec 2011
$4.16 B(+825.6%)
$4.16 B(+205.7%)
Sept 2011
-
$1.36 B(-18.6%)
June 2011
-
$1.67 B(+302.8%)
Mar 2011
-
$414.61 M(-7.7%)
Dec 2010
$449.13 M
$449.13 M(-26.3%)
Sept 2010
-
$609.61 M(-9.9%)
June 2010
-
$676.87 M(-56.9%)
DateAnnualQuarterly
Mar 2010
-
$1.57 B(-34.0%)
Dec 2009
$2.38 B(+69.9%)
$2.38 B(-21.2%)
Sept 2009
-
$3.02 B(+54.7%)
June 2009
-
$1.95 B(+6.6%)
Mar 2009
-
$1.83 B(+30.7%)
Dec 2008
$1.40 B(-79.9%)
$1.40 B(-43.3%)
Sept 2008
-
$2.47 B(+7.2%)
June 2008
-
$2.31 B(-35.4%)
Mar 2008
-
$3.57 B(-48.8%)
Dec 2007
$6.97 B(+395.7%)
$6.97 B(+70.9%)
Sept 2007
-
$4.08 B(+72.8%)
June 2007
-
$2.36 B(-0.5%)
Mar 2007
-
$2.37 B(+68.7%)
Dec 2006
$1.41 B(-61.0%)
$1.41 B(+15.0%)
Sept 2006
-
$1.22 B(+19.0%)
June 2006
-
$1.03 B(-31.5%)
Mar 2006
-
$1.50 B(-58.4%)
Dec 2005
$3.60 B(+18.7%)
$3.60 B(+26.3%)
Sept 2005
-
$2.85 B(-6.8%)
June 2005
-
$3.06 B(-4.0%)
Mar 2005
-
$3.18 B(+4.9%)
Dec 2004
$3.03 B(+17.1%)
$3.03 B(+44.7%)
Sept 2004
-
$2.10 B(+5.1%)
June 2004
-
$1.99 B(-22.4%)
Mar 2004
-
$2.57 B(-0.9%)
Dec 2003
$2.59 B(+3.7%)
$2.59 B(-2.3%)
Sept 2003
-
$2.65 B(+17.3%)
June 2003
-
$2.26 B(+8.1%)
Mar 2003
-
$2.09 B(-16.3%)
Dec 2002
$2.50 B(-18.9%)
$2.50 B(-8.8%)
Sept 2002
-
$2.74 B(-29.2%)
June 2002
-
$3.88 B(+32.8%)
Mar 2002
-
$2.92 B(-5.3%)
Dec 2001
$3.08 B(-9.3%)
$3.08 B(+11.0%)
Sept 2001
-
$2.78 B(-0.4%)
June 2001
-
$2.79 B(-16.9%)
Mar 2001
-
$3.36 B(-1.3%)
Dec 2000
$3.40 B(-6.5%)
$3.40 B(-24.1%)
Sept 2000
-
$4.48 B(-4.4%)
June 2000
-
$4.69 B(-2.7%)
Mar 2000
-
$4.82 B(+32.5%)
Dec 1999
$3.64 B(+66.9%)
$3.64 B(+17.7%)
June 1999
-
$3.09 B(+41.9%)
Dec 1998
$2.18 B(+11.4%)
$2.18 B(+4.0%)
June 1998
-
$2.10 B(+7.1%)
Dec 1997
$1.96 B(-25.6%)
$1.96 B(-25.6%)
Dec 1996
$2.63 B(-43.6%)
$2.63 B(+79.2%)
Dec 1995
$4.66 B(+217.8%)
-
June 1995
-
$1.47 B(+137.9%)
June 1995
$1.47 B(+137.9%)
-
June 1994
$616.20 M(-31.6%)
$616.20 M(-31.6%)
June 1993
$900.69 M(+29.5%)
$900.69 M(+29.5%)
June 1992
$695.40 M(-50.8%)
$695.40 M(-50.8%)
June 1991
$1.41 B(+90.7%)
$1.41 B(+90.7%)
June 1990
$740.77 M(+236.6%)
$740.77 M(+236.6%)
June 1989
$220.07 M(-48.9%)
$220.07 M(-48.9%)
June 1988
$430.63 M(+35.8%)
$430.63 M(+35.8%)
June 1987
$317.15 M(+95.5%)
$317.15 M(+95.5%)
June 1986
$162.24 M
$162.24 M

FAQ

  • What is GSK annual short term debt?
  • What is the all time high annual short term debt for GSK?
  • What is GSK annual short term debt year-on-year change?
  • What is GSK quarterly short term debt?
  • What is the all time high quarterly short term debt for GSK?
  • What is GSK quarterly short term debt year-on-year change?

What is GSK annual short term debt?

The current annual short term debt of GSK is $3.58 B

What is the all time high annual short term debt for GSK?

GSK all-time high annual short term debt is $9.07 B

What is GSK annual short term debt year-on-year change?

Over the past year, GSK annual short term debt has changed by -$1.20 B (-25.07%)

What is GSK quarterly short term debt?

The current quarterly short term debt of GSK is $3.77 B

What is the all time high quarterly short term debt for GSK?

GSK all-time high quarterly short term debt is $12.86 B

What is GSK quarterly short term debt year-on-year change?

Over the past year, GSK quarterly short term debt has changed by -$2.14 B (-36.25%)